Zepp Health (NYSE:ZEPP – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday.
Separately, Fundamental Research set a $53.01 target price on shares of Zepp Health and gave the company a “buy” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $53.01.
Check Out Our Latest Research Report on ZEPP
Zepp Health Price Performance
Insider Activity
In related news, CFO Cheng Deng sold 9,836 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $4.61, for a total transaction of $45,343.96. Following the completion of the sale, the chief financial officer directly owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. This trade represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by corporate insiders.
Institutional Trading of Zepp Health
Large investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio purchased a new stake in shares of Zepp Health during the 3rd quarter worth approximately $43,000. Osaic Holdings Inc. lifted its holdings in Zepp Health by 239.5% during the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after purchasing an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP bought a new position in Zepp Health during the fourth quarter worth about $241,000. Capstone Capital Management Ltd bought a new position in Zepp Health during the fourth quarter worth about $298,000. Finally, Mangrove Partners IM LLC purchased a new position in shares of Zepp Health in the fourth quarter worth about $387,000. Hedge funds and other institutional investors own 52.61% of the company’s stock.
About Zepp Health
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Featured Articles
- Five stocks we like better than Zepp Health
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
